Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Gamma-Aminobutyric Acid (GABA) Receptor market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.0% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Segmentations:

    By Player:

    • AstraZeneca

    • XenoPort

    • Elan Corporation

    • Pfizer

    • H.LundBeck

    • Advicenne

    • Biocodex

    • HLundBeck

    • Novartis

    • OVATION Pharmaceuticals

    • VIVUS

    • Osmotica Pharmaceutical

    • Eli Lilly & Company

    • sanofi-aventis

    • NovaDel Pharma

    • GlaxoSmithKline

    By Type:

    • GABAA

    • GABAB

    By End-User:

    • Attention Deficit Hyperactivity Disorder

    • Psychiatric Disorders

    • Alzheimer's Disease

    • Chronic Obstructive Pulmonary Disease

    • Memory Impairment

    • Other

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gamma-Aminobutyric Acid (GABA) Receptor Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of GABAA from 2014 to 2026

    • 1.3.2 Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of GABAB from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder from 2014 to 2026

    • 1.4.2 Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Psychiatric Disorders from 2014 to 2026

    • 1.4.3 Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • 1.4.4 Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Chronic Obstructive Pulmonary Disease from 2014 to 2026

    • 1.4.5 Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Memory Impairment from 2014 to 2026

    • 1.4.6 Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gamma-Aminobutyric Acid (GABA) Receptor Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gamma-Aminobutyric Acid (GABA) Receptor by Major Types

      • 3.4.1 Market Size and Growth Rate of GABAA

      • 3.4.2 Market Size and Growth Rate of GABAB

    4 Segmentation of Gamma-Aminobutyric Acid (GABA) Receptor Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gamma-Aminobutyric Acid (GABA) Receptor by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor for Attention Deficit Hyperactivity Disorder

      • 4.4.2 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor for Psychiatric Disorders

      • 4.4.3 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor for Alzheimer's Disease

      • 4.4.4 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor for Chronic Obstructive Pulmonary Disease

      • 4.4.5 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor for Memory Impairment

      • 4.4.6 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor for Other

    5 Market Analysis by Major Regions

    • 5.1 Europe Gamma-Aminobutyric Acid (GABA) Receptor Production Analysis by Top Regions

    • 5.2 Europe Gamma-Aminobutyric Acid (GABA) Receptor Consumption Analysis by Top Regions

    • 5.3 Europe Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.3 France Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    6 Product Circulation of Gamma-Aminobutyric Acid (GABA) Receptor Market among Top Countries

    • 6.1 Top 5 Export Countries in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 7.1 Germany Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 7.2 Germany Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    8. UK Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 8.1 UK Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 8.2 UK Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    9. France Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 9.1 France Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 9.2 France Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    10. Italy Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 10.1 Italy Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 10.2 Italy Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    11. Spain Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 11.1 Spain Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 11.2 Spain Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    12. Poland Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 12.1 Poland Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 12.2 Poland Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    13. Russia Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 13.1 Russia Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 13.2 Russia Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    14. Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 14.1 Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 14.2 Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    15. Turkey Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 15.1 Turkey Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 15.2 Turkey Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Top Countries

      • 16.3.1 Denmark Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

      • 16.3.2 Finland Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

      • 16.3.3 Norway Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

      • 16.3.4 Sweden Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

      • 16.3.6 Iceland Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Top Countries

      • 17.3.1 Belgium Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

      • 17.3.2 Netherlands Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

      • 17.3.3 Luxembourg Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Top Countries

      • 18.3.1 Estonia Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

      • 18.3.2 Latvia Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

      • 18.3.3 Lithuania Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 AstraZeneca

      • 19.1.1 AstraZeneca Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 XenoPort

      • 19.2.1 XenoPort Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Elan Corporation

      • 19.3.1 Elan Corporation Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Pfizer

      • 19.4.1 Pfizer Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 H.LundBeck

      • 19.5.1 H.LundBeck Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Advicenne

      • 19.6.1 Advicenne Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Biocodex

      • 19.7.1 Biocodex Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 HLundBeck

      • 19.8.1 HLundBeck Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Novartis

      • 19.9.1 Novartis Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 OVATION Pharmaceuticals

      • 19.10.1 OVATION Pharmaceuticals Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 VIVUS

      • 19.11.1 VIVUS Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Osmotica Pharmaceutical

      • 19.12.1 Osmotica Pharmaceutical Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Eli Lilly & Company

      • 19.13.1 Eli Lilly & Company Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 sanofi-aventis

      • 19.14.1 sanofi-aventis Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 NovaDel Pharma

      • 19.15.1 NovaDel Pharma Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 GlaxoSmithKline

      • 19.16.1 GlaxoSmithKline Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    The List of Tables and Figures (Totals 90 Figures and 152 Tables)

    • Figure Product Picture

    • Figure Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of GABAA from 2014 to 2026

    • Figure Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of GABAB from 2014 to 2026

    • Figure Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder from 2014 to 2026

    • Figure Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Psychiatric Disorders from 2014 to 2026

    • Figure Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • Figure Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Chronic Obstructive Pulmonary Disease from 2014 to 2026

    • Figure Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Memory Impairment from 2014 to 2026

    • Figure Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Germany Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure UK Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure France Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gamma-Aminobutyric Acid (GABA) Receptor Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gamma-Aminobutyric Acid (GABA) Receptor

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gamma-Aminobutyric Acid (GABA) Receptor by Different Types from 2014 to 2026

    • Table Consumption Share of Gamma-Aminobutyric Acid (GABA) Receptor by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of GABAA

    • Figure Market Size and Growth Rate of GABAB

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gamma-Aminobutyric Acid (GABA) Receptor by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gamma-Aminobutyric Acid (GABA) Receptor by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder

    • Figure Market Size and Growth Rate of Psychiatric Disorders

    • Figure Market Size and Growth Rate of Alzheimer's Disease

    • Figure Market Size and Growth Rate of Chronic Obstructive Pulmonary Disease

    • Figure Market Size and Growth Rate of Memory Impairment

    • Figure Market Size and Growth Rate of Other

    • Table Europe Gamma-Aminobutyric Acid (GABA) Receptor Production by Major Regions

    • Table Europe Gamma-Aminobutyric Acid (GABA) Receptor Production Share by Major Regions

    • Figure Europe Gamma-Aminobutyric Acid (GABA) Receptor Production Share by Major Countries and Regions in 2014

    • Table Europe Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Major Regions

    • Table Europe Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Major Regions

    • Table Germany Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table UK Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table France Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Italy Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Spain Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Poland Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Russia Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Turkey Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Gamma-Aminobutyric Acid (GABA) Receptor Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Germany Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Germany Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Germany Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table UK Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table UK Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table UK Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table UK Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table France Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table France Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table France Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table France Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Italy Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Italy Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Italy Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Italy Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Spain Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Spain Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Spain Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Spain Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Poland Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Poland Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Poland Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Poland Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Russia Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Russia Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Russia Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Russia Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Switzerland Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Turkey Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Turkey Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Turkey Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Gamma-Aminobutyric Acid (GABA) Receptor Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of XenoPort

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of XenoPort

    • Figure Sales and Growth Rate Analysis of XenoPort

    • Figure Revenue and Market Share Analysis of XenoPort

    • Table Product and Service Introduction of XenoPort

    • Table Company Profile and Development Status of Elan Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elan Corporation

    • Figure Sales and Growth Rate Analysis of Elan Corporation

    • Figure Revenue and Market Share Analysis of Elan Corporation

    • Table Product and Service Introduction of Elan Corporation

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of H.LundBeck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of H.LundBeck

    • Figure Sales and Growth Rate Analysis of H.LundBeck

    • Figure Revenue and Market Share Analysis of H.LundBeck

    • Table Product and Service Introduction of H.LundBeck

    • Table Company Profile and Development Status of Advicenne

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advicenne

    • Figure Sales and Growth Rate Analysis of Advicenne

    • Figure Revenue and Market Share Analysis of Advicenne

    • Table Product and Service Introduction of Advicenne

    • Table Company Profile and Development Status of Biocodex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocodex

    • Figure Sales and Growth Rate Analysis of Biocodex

    • Figure Revenue and Market Share Analysis of Biocodex

    • Table Product and Service Introduction of Biocodex

    • Table Company Profile and Development Status of HLundBeck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HLundBeck

    • Figure Sales and Growth Rate Analysis of HLundBeck

    • Figure Revenue and Market Share Analysis of HLundBeck

    • Table Product and Service Introduction of HLundBeck

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of OVATION Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OVATION Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of OVATION Pharmaceuticals

    • Figure Revenue and Market Share Analysis of OVATION Pharmaceuticals

    • Table Product and Service Introduction of OVATION Pharmaceuticals

    • Table Company Profile and Development Status of VIVUS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of VIVUS

    • Figure Sales and Growth Rate Analysis of VIVUS

    • Figure Revenue and Market Share Analysis of VIVUS

    • Table Product and Service Introduction of VIVUS

    • Table Company Profile and Development Status of Osmotica Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Osmotica Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Osmotica Pharmaceutical

    • Figure Revenue and Market Share Analysis of Osmotica Pharmaceutical

    • Table Product and Service Introduction of Osmotica Pharmaceutical

    • Table Company Profile and Development Status of Eli Lilly & Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly & Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly & Company

    • Figure Revenue and Market Share Analysis of Eli Lilly & Company

    • Table Product and Service Introduction of Eli Lilly & Company

    • Table Company Profile and Development Status of sanofi-aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of sanofi-aventis

    • Figure Sales and Growth Rate Analysis of sanofi-aventis

    • Figure Revenue and Market Share Analysis of sanofi-aventis

    • Table Product and Service Introduction of sanofi-aventis

    • Table Company Profile and Development Status of NovaDel Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NovaDel Pharma

    • Figure Sales and Growth Rate Analysis of NovaDel Pharma

    • Figure Revenue and Market Share Analysis of NovaDel Pharma

    • Table Product and Service Introduction of NovaDel Pharma

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.